Dr. David Dingli of the Mayo Clinic in Rochester, Minnesota, was the guest speaker at the July meeting of the Stillwater, MN, Multiple Myeloma Support Group. Takeda Pharmaceuticals provided lunch for the very large crowd in attendance.
Dr. Dingli gave a very helpful presentation on the results of several recent clinical trials. Additionally, Dr. Dingli discussed many of the current treatments that are available to Myeloma patients as well as some of the new drugs that currently being tested in clinical trials. Dr. Dingli discussed some of the reported side effects of various treatments and encouraged patients to report any such issues to their physicians.
– Bev Culy